skip to main content

H.R. 1520: Purple Book Continuity Act of 2019

Call or Write Congress

React to this bill with an emoji

Save your opinion on this bill on a six-point scale from strongly oppose to strongly support

Add Note All Positions »
(About Ads | Hide These Ads)

To amend the Public Health Service Act to provide for the publication of a list of licensed biological products, and for other purposes.

The bill’s titles are written by its sponsor.

Sponsor and status

Photo of sponsor Anna Eshoo

Anna Eshoo

Sponsor. Representative for California's 18th congressional district. Democrat.

Thumbnail of bill text
Read Text »
Last Updated: May 9, 2019
Length: 6 pages
Introduced
Mar 5, 2019
Status

Passed House (Senate next) on May 8, 2019

This bill passed in the House on May 8, 2019 and goes to the Senate next for consideration.

Prognosis
21% chance of being enacted according to Skopos Labs (details)
Source
Congress.gov

Position statements

What legislators are saying

“My Votes – Week of May 6”
    — Rep. Cathy McMorris Rodgers [R-WA5] on May 10, 2019

“Upton votes for legislation to lower drug prices”
    — Rep. Fred Upton [R-MI6] on May 8, 2019

“Congresswoman Gwen Moore (WI-4) Statement On Reports that Drug Companies Are Conspiring To Raise the Costs of Generic Prescription Drugs”
    — Rep. Gwen Moore [D-WI4] on May 13, 2019

More statements at ProPublica Represent...

What stakeholders are saying

Institute for Spending Reform: SpendingTracker.org estimates H.R. 1520 will add $3 million in new spending through 2024.

History

Mar 5, 2019
 
Introduced

Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.

Read Text »

Mar 27, 2019
 
Considered by Health

A committee held a hearing or business meeting about the bill.

Apr 3, 2019
 
Ordered Reported

A committee has voted to issue a report to the full chamber recommending that the bill be considered further. Only about 1 in 4 bills are reported out of committee.

Read Updated Text » See Changes »

May 3, 2019
 
Reported by House Committee on Energy and Commerce

A committee issued a report on the bill, which often provides helpful explanatory background on the issue addressed by the bill and the bill's intentions.

Read Report »

May 8, 2019
 
Passed House (Senate next)

The bill was passed in a vote in the House. It goes to the Senate next.

thumbnail image of vote View Vote » Read Updated Text » See Changes »

If this bill has further action, the following steps may occur next:
—
 
Passed Senate

—
 
Signed by the President

H.R. 1520 is a bill in the United States Congress.

A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

How to cite this information.

We recommend the following MLA-formatted citation when using the information you see here in academic work:

“H.R. 1520 — 116th Congress: Purple Book Continuity Act of 2019.” www.GovTrack.us. 2019. August 20, 2019 <https://www.govtrack.us/congress/bills/116/hr1520>

Where is this information from?

GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.